DARPA’s Biological Technologies Office (BTO) develops capabilities that embrace the unique properties of biology and applies those features to revolutionize how the United States protects its Warfighters.
This grant is outlined in the Broad Agency Announcement (BAA), which invites proposals for research and development in biotechnology to support the mission of improving defense capabilities through biological systems. The grant program emphasizes developing technologies that enhance the resilience, recovery, and readiness of military personnel, create innovative materials, and ensure the security of the homeland against biological threats. Proposals can be submitted on a rolling basis until June 20, 2024, and will follow all relevant laws and regulations in negotiation and award processes, with a particular reference to procedures under the Federal Acquisition Regulation (FAR) for contract pricing.